DBV Technologies | DBVT - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
Acadia Pharmaceuticals USD 4.53B 199M 2026-08
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amarin USD 290M 51M 2025-12
BioCryst Pharmaceuticals USD 1.9B 643M 2026-08
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
DBV Technologies USD 1.23B 327M 2026-03
Halozyme Therapeutics USD 10.91B 1.63B 2026-08
Incyte USD 26.84B 4.19B 2026-08
Insmed USD 19.68B 3.43B 2026-08
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Sarepta Therapeutics USD 1.5B 402M 2026-08
Ultragenyx Pharmaceutical USD 2.12B 1.16B 2026-08
United Therapeutics USD 24.42B 1.42B 2026-08